NTRA Approves Safety, Integrity Code of Standards Updates
Edited Press Release
October 24, 2016
Updates include a January 2019 deadline for total compliance with the National Uniform Medication Program.
Updates include a January 2019 deadline for total compliance with the National Uniform Medication Program.
Houkoumi G tested positive for O-desmethyltramadol after finishing third in an endurance ride in September.
This means back-to-back clean Paralympic games (London 2012 and Rio 2016) for para-equestrian participants.
The NYDTL is the eighth laboratory to become accredited by the RMTC since 2013.
A total of 60 equine samples–30% of the 200 competing horses–were tested during the Games.
Researchers will be studying the use of biomarkers drug testing.
Several horses had allegedly received clenbuterol, and groom Marian Vega was found to be in possession of the drug.
Pennsylvania is the 10th state to fully adopt the National Uniform Medication Program.
The cases focus on prohibited substances identified in a para-dressage horse, an endurance horse, and a jumping horse.
The horse Lunatica tested positive for two prohibited substances: propranolol and dexamethasone.
The Jordanian horse tested positive for boldenone, dexamethasone, meloxicam, phenylbutazone, and oxyphenbutazone.
Carolyn Cooper, DVM, is the director of the Canadian Pari-Mutuel Agency’s Equine Drug Control Program.
The top two finishers at an event in Doha earlier this year have tested positive for human erythropoietin (EPO).
Glaucine, thought to have bronchodilatory and anti-inflammatory properties, is found in the tulip poplar tree.
Researchers in the club’s Racing Laboratory are studying biomarkers for use in drug testing.
Representatives educated Congress members about the Thoroughbred Horseracing Integrity Act of 2015.
Stay on top of the most recent Horse Health news with
